301190实控人“婚变”分股，前妻接管公司

Core Viewpoint - The recent changes in the ownership structure of Shanshui Technology, including the divorce and subsequent share redistribution between the actual controllers, have raised concerns about the company's internal governance capabilities [2][5]. Group 1: Ownership Changes - On November 7, Shanshui Technology announced that the actual controllers, Huang Guorong and Wu Xinyan, have divorced, leading to a redistribution of shares. Wu Xinyan received 10 million shares directly from Huang Guorong [2]. - Before the share redistribution, Huang Guorong and Wu Xinyan collectively held 98.79 million shares, approximately 46.03% of the total share capital. Huang Guorong directly held 40 million shares (18.64%), while Wu Xinyan directly held 25 million shares (11.65%) [4][5]. - After the redistribution, Huang Guorong holds 30.22 million shares (14.08%), while Wu Xinyan now holds 68.57 million shares (31.95%), making her the new actual controller and majority shareholder of the company [5][7]. Group 2: Management Changes - Following the divorce and share redistribution, Huang Guorong submitted his resignation as chairman and general manager of Shanshui Technology, citing personal reasons. Wu Xinyan has been elected as the new chairman and is set to be appointed as the general manager [7]. - The change in control occurred shortly after Huang Guorong was subjected to criminal coercive measures, which were disclosed on October 20, indicating a rapid succession of events impacting the company's leadership [7]. Group 3: Company Performance - In the first half of 2025, Shanshui Technology reported a revenue of 305 million yuan, representing a year-on-year increase of 23.08%. However, the net profit attributable to shareholders decreased by 11.77% to 47.77 million yuan [9]. - As of November 7, the company's stock closed at 24.38 yuan per share, with a total market capitalization of 5.233 billion yuan [10]. Group 4: Business Overview - Shanshui Technology specializes in the research, production, and sales of dye intermediates, pesticides, and pharmaceutical intermediates. Key products include various dye intermediates and chlorinated pyridine series products [8].